Oct 3, 20221 min readZYNLONTA: The first and only CD19-direct ADC for 3L DLBCL ~ November 11th, 2022Full flyer info: Atalntic Fish Nov. 11th Nursing Program.pdfDownload PDF • 1.46MB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Commentaires